Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting ...

There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...

Subcutaneous ocrelizumab and hyaluronidase (Ocrevus Zunovo) was approved for relapsing and progressive multiple sclerosis, ...

Alzheimer's disease is becoming more prevalent due to lifestyle factors like inactivity, poor diet, loneliness, inadequate ...

A notable trend becomes apparent when comparing deaths linked to Alzheimer’s with those from heart disease, the leading cause ...

Amyloid-beta and tau proteins have long been associated with Alzheimer's disease. The pathological buildup of these proteins ...

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...

Alzheimer's disease primarily affects older adults, leading to cognitive decline. Preventive measures include a healthy ...

The failure to diagnose Alzheimer's disease—the most common form of dementia in the elderly—at an early stage of molecular ...

Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.